Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Femoral Shaft Fractures
NCT04803591Phase 4Withdrawn
- Sponsor
- Christian Candrian
- Start
- Aug 2021
- Primary completion
- Sep 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of tranexamic acid in femoral shaft fracture, sponsored by Christian Candrian. Planned start Aug 2021; status: withdrawn.
02
Drugs
tranexamic acid
03
Conditions
femoral shaft fracture
Beyond the preview
Go deeper on NCT04803591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04803591.